All data are based on the daily closing price as of July 12, 2024
s

Shinpoong Pharm

019170.KO
8.90 USD
0.24
+2.77%

Overview

Last close
8.90 usd
Market cap
438.67M usd
52 week high
17.19 usd
52 week low
8.13 usd
Target price
4.2 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
3.3712
Price/Book Value
2.6158
Enterprise Value
449.27M usd
EV/Revenue
3.4409
EV/EBITDA
-17.3042

Key financials

Revenue TTM
149.87M usd
Gross Profit TTM
56.34M usd
EBITDA TTM
-19.69M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
256.86M usd
Net debt
N/A usd

About

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.
  • Symbol
    019170.KO
  • Exchange
    KO
  • Isin
    KR7019170000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://shinpoong.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top